Progressive Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-72,030
Closed -$1.29M 52
2016
Q4
$1.29M Sell
72,030
-2,014
-3% -$36.5K 1.18% 36
2016
Q3
$1.54M Buy
74,044
+586
+0.8% +$14.5K 1.43% 35
2016
Q2
$1.98M Buy
73,458
+1,434
+2% +$39.3K 1.91% 31
2016
Q1
$1.95M Sell
72,024
-36,928
-34% -$989K 1.98% 30
2015
Q4
$3.16M Sell
108,952
-5,856
-5% -$162K 3.38% 3
2015
Q3
$3.11M Sell
114,808
-5,732
-5% -$162K 3.59% 3
2015
Q2
$3.3M Buy
120,540
+92,416
+329% +$2.6M 3.63% 2
2015
Q1
$750K Sell
28,124
-25,232
-47% -$581K 2.59% 11
2014
Q4
$1.13M Sell
53,356
-22,124
-29% -$494K 0.39% 40
2014
Q3
$1.8M Hold
75,480
0.62% 38
2014
Q2
$1.74M Sell
75,480
-214
-0.3% -$4.72K 0.56% 40
2014
Q1
$1.73M Sell
75,694
-15,626
-17% -$333K 0.55% 40
2013
Q4
$1.69M Sell
91,320
-2,260
-2% -$39.4K 0.58% 39
2013
Q3
$1.58M Sell
93,580
-3,250
-3% -$54.7K 0.59% 38
2013
Q2
$1.5M Buy
+96,830
New +$1.61M 0.58% 38

Other funds holding NVO

Progressive Investment Management's NVO Position: Q1 2017 in Review

Progressive Investment Management sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 72,030 shares — an estimated $1.29M sold.

Progressive Investment Management first reported a position in NVO in Q2 2013 and held it in 15 quarters. The position peaked at $3.3M in Q2 2015. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • Progressive Investment Management reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • Progressive Investment Management sold 72,030 Novo Nordisk shares in Q1 2017, an estimated $1.29M.
  • Progressive Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 15 quarters.
  • Progressive Investment Management's Novo Nordisk position peaked at $3.3M in Q2 2015.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Progressive Investment Management's 13F filing for Q1 2017, filed 25 Apr 2017.